Carcinoembryonic Antigen (CEA) is a 180-200 KD glycoprotein expressed at high level in the epithelial cells of the embryonic colon. The expression is stopped after birth. CEA serum content is low in normal population and only slightly elevated in heavy smokers. Increased serum CEA level was found to be associated with colorectal carcinoma, gastric carcinoma, pancreatic carcinoma, lung carcinoma, and breast carcinoma. However elevated CEA level does not necessarily indicate neoplastic conditions. CEA level is useful for monitoring tumour recurrence after surgical resection of carcinoma.

ARG30066 Carcinoembryonic Antigen ELISA Duos, includes a capture antibody, ARG10188 CEA antibody [CEA-Y1] and a HRP-conjugated tracer antibody, ARG10189 CEA antibody [CEA-Y2] (HRP), for studying Carcinoembryonic Antigen (CEA) protein expression level by ELISA.